CLASS II Drug recall · Reported 17 Jan 2018 · FDA Enforcement Report

Human Chorionic Gonadotropin (ODT) recalled by KRS Global Biotechnology

KRS Global Biotechnology is recalling Human Chorionic Gonadotropin (ODT), distributed nationwide in the US. The recall was initiated on 16 Nov 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 06132017@22 BUD: 12/10/2017
Quantity recalled2,239 tablets

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0173-2018
FDA event ID
78553
Recalling firm
KRS Global Biotechnology, Boca Raton, FL
Classification
Class II
Status
Terminated
Recall initiated
16 Nov 2017
FDA classified
8 Jan 2018
Reported
17 Jan 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

16 Nov 2017Recall initiated by company
8 Jan 2018Classified by FDA+53 days
17 Jan 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Product as listed by the FDA

Human Chorionic Gonadotropin 500 iu Orally Disintegrating Tablets (ODT), Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.

Where it was distributed

Nationwide in the USA, Bermuda, and New Zealand

Nationwide

Questions about this recall

Is Human Chorionic Gonadotropin (ODT) recalled?

Yes. KRS Global Biotechnology recalled Human Chorionic Gonadotropin (ODT) on 16 Nov 2017. The recall is Class II and its status is Terminated. Recall number D-0173-2018.

Why was it recalled?

Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.

Which lots are affected?

Lot: 06132017@22 BUD: 12/10/2017

Where was it sold?

Nationwide in the USA, Bermuda, and New Zealand

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from KRS Global Biotechnology

All 129